Barr E S & CO Pfizer Inc Transaction History

Barr E S & CO

$1.57 Billion
Q3 2024

A detailed history of Barr E S & CO transactions in Pfizer Inc stock. As of the latest transaction made, Barr E S & CO holds 7,680 shares of PFE stock, worth $201,292. This represents 0.01% of its overall portfolio holdings.

Number of Shares

7,680

Previous 8,768 12.41%

Holding current value

$201,292

Previous $245,000 9.39%

% of portfolio

0.01%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$27.7 - $31.39 $30,137 - $34,152	-1,088 Reduced 12.41%	7,680 $222,000
Q2 2024 Aug 14, 2024	SELL	$25.26 - $29.6 $3,536 - $4,144	-140 Reduced 1.57%	8,768 $245,000
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $24,466 - $28,094	-945 Reduced 9.59%	8,908 $247,000
Q4 2023 Feb 09, 2024	BUY	$26.13 - $33.94 $24,692 - $32,073	945 Added 10.61%	9,853 $283,000
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $3,209 - $3,751	-100 Reduced 1.11%	8,908 $295,000
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $59,085 - $76,920	-1,500 Reduced 14.27%	9,008 $367,000
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $22,142 - $27,030	-506 Reduced 4.59%	10,508 $460,000
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $155,503 - $184,378	-3,342 Reduced 23.28%	11,014 $577,000
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $45,750 - $56,690	-1,000 Reduced 6.51%	14,356 $743,000
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $2,355 - $3,491	-57 Reduced 0.37%	15,356 $907,000
Q3 2021 Nov 10, 2021	BUY	$39.25 - $50.42 $2,237 - $2,873	57 Added 0.37%	15,413 $663,000
Q2 2021 Aug 13, 2021	BUY	$35.91 - $40.68 $109,094 - $123,585	3,038 Added 24.66%	15,356 $601,000
Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $2,511 - $2,832	-75 Reduced 0.61%	12,318 $446,000
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $93,716 - $119,168	2,800 Added 29.19%	12,393 $456,000
Q3 2020 Nov 13, 2020	SELL	$31.75 - $37.25 $9,874 - $11,584	-311 Reduced 3.14%	9,593 $352,000
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $36,144 - $43,848	-1,200 Reduced 10.81%	9,904 $324,000
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $57,519 - $82,183	-2,128 Reduced 16.08%	11,104 $362,000
Q2 2019 Aug 08, 2019	SELL	$36.98 - $41.52 $13,238 - $14,864	-358 Reduced 2.63%	13,232 $573,000
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $51,450 - $56,526	-1,372 Reduced 9.17%	13,590 $577,000
Q3 2018 Nov 07, 2018	BUY	$34.47 - $41.81 $1,103 - $1,337	32 Added 0.21%	14,962 $659,000
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $9,924 - $11,513	311 Added 2.13%	14,930 $530,000
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $2,328 - $2,470	70 Added 0.48%	14,619 $530,000
Q3 2017 Nov 09, 2017	BUY	$31.0 - $34.15 $451,019 - $496,848	14,549	14,549 $519,000

Others Institutions Holding PFE

# of Institutions

3,258

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $147B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barr E S & CO, based on Form 13F filings with the SEC.

News

Stay updated on Barr E S & CO with notifications on news.

Account